Daxor (DXR) Stock: Buy, Sell, or Hold?
DXR - Daxor Corporation Common Stock
$11.47
0.63 (5.81%)
▲
5d:
+8.72%
30d:
+13.45%
90d:
+10.77%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Get Alerted When DXR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: DXR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: DXR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: DXR is currently trading at $11.47, which is considered extended relative to its 30-day fair value range of $10.03 to $10.78.
Technical Outlook: Technically, DXR is in a uptrend. The price is approaching resistance at $11.38. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: DXR scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+84.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DXR is in a uptrend. The price is approaching resistance at $11.38. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: DXR scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+84.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.03 -
$10.78
Company Quality Score
39/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+6.4% above its trading range)
- BEARISH: Weak technical setup (33/100)
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 84.5% below Wall St target ($20.00)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.03 -
$10.78
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.65
Resistance Level
$11.38
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-361.33
Wall Street Target
$20.00
(+84.5%)
Revenue Growth (YoY)
25.5%
Earnings Growth (YoY)
329.3%
Profit Margin
19861.4%
Share & Embed Analysis
Last updated: September 11, 2026 4:06 PM ET
Data refreshes hourly during market hours. Next update: 5:06 PM
Data refreshes hourly during market hours. Next update: 5:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DXR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael Richard Feldschuh
BUY
1000 shares
2026-04-08
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
